{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:14:39Z","timestamp":1762917279182},"reference-count":58,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2010,7,15]],"date-time":"2010-07-15T00:00:00Z","timestamp":1279152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:p>Dystonia in the neck region can be safely and effectively reduced with injections of Botulinum neurotoxin\u2010A and B. People with idiopathic cervical dystonia have been studied the most. Benefits following injection include increased range of movement at the neck for head turning, decreased pain, and increased functional capacity (Class I evidence, level A recommendation). The evidence for efficacy and safety in patients with secondary dystonia in the neck is unclear based on the lack of rigorous research conducted in this heterogeneous population (level U recommendation). Psychometrically sound assessments and outcome measures exist to guide decision\u2010making (Class I evidence, level A recommendation). Much less is known about the effectiveness of therapy to augment the effects of the injection (Class IV, level U recommendation). More research is needed to answer questions about safety and efficacy in secondary spastic neck dystonia, effective adjunctive therapy, dosing and favourable injection techniques.<\/jats:p>","DOI":"10.1111\/j.1468-1331.2010.03130.x","type":"journal-article","created":{"date-parts":[[2010,7,15]],"date-time":"2010-07-15T11:48:06Z","timestamp":1279194486000},"page":"94-108","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Botulinum toxin assessment, intervention and aftercare for cervical dystonia and other causes of hypertonia of the neck: international consensus statement"],"prefix":"10.1111","volume":"17","author":[{"given":"I.","family":"Novak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. S. C.","family":"Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,7,15]]},"reference":[{"key":"e_1_2_11_2_2","unstructured":"American Academy of Neurology.AAN classification of evidence for therapeutic intervention.2004. Available online:http:\/\/www.neurology.org."},{"key":"e_1_2_11_3_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1959.16.1.0055"},{"key":"e_1_2_11_4_2","unstructured":"RamachandranTS MolloyFM. Botulinum Toxin (BOTOX\u00ae) Dystonia Treatment. E\u2010Medicine 2008. Available online:http:\/\/emedicine.medscape.com\/article\/1153958\u2010overviewaccessed: 20 June 2009."},{"key":"e_1_2_11_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.4.616"},{"key":"e_1_2_11_6_2","first-page":"787","article-title":"The Epidemiological Study of Dystonia in Europe (ESDE) collaborative group","volume":"247","author":"ESDE","year":"2000","journal-title":"J Neurol"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870030302"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1990.00530050070014"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870060206"},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8619(08)80005-9"},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/da.10039"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000142962.11881.26"},{"key":"e_1_2_11_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000249310.25427.f2"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.1155\/1990\/764203"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.1.73"},{"key":"e_1_2_11_16_2","first-page":"211","volume-title":"Therapy with Botulinum Toxin","author":"Consky E","year":"1994"},{"key":"e_1_2_11_17_2","first-page":"445","article-title":"The Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS): assessment of the validity and inter\u2010rater reliability","volume":"40","author":"Consky ES","year":"1990","journal-title":"Neurology"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10377"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700009855"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3999(91)90044-O"},{"key":"e_1_2_11_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21392"},{"key":"e_1_2_11_22_2","first-page":"153","article-title":"Quality of life in patients with craniocervical dystonia: development of the CDQ\u201024","volume":"15","author":"Muller J","year":"2000","journal-title":"Mov Disord"},{"key":"e_1_2_11_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiomech.2005.11.011"},{"key":"e_1_2_11_24_2","doi-asserted-by":"publisher","DOI":"10.1155\/1996\/292504"},{"key":"e_1_2_11_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120117"},{"key":"e_1_2_11_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)92070-2"},{"key":"e_1_2_11_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120516"},{"key":"e_1_2_11_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.63.5.642"},{"key":"e_1_2_11_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.4.769"},{"key":"e_1_2_11_30_2","first-page":"1","article-title":"Botulinum toxin type A in the treatment of patients with cervical dystonia","volume":"3","author":"Brashear A","year":"2009","journal-title":"Biologics"},{"key":"e_1_2_11_31_2","article-title":"Botulinum toxin type B for cervical dystonia","author":"Costa J","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_32_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.1.189"},{"key":"e_1_2_11_33_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000183055.81056.5c"},{"key":"e_1_2_11_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.07.020"},{"key":"e_1_2_11_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.64.1.6"},{"key":"e_1_2_11_36_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000163767.99354.C3"},{"key":"e_1_2_11_37_2","first-page":"CD003633","article-title":"Botulinum toxin type A therapy for cervical dystonia","volume":"1","author":"Costa J","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004150170028"},{"key":"e_1_2_11_39_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.64.1.13"},{"key":"e_1_2_11_40_2","first-page":"189","article-title":"Double\u2010blind, placebo\u2010controlled study of botulinum toxin injections in the treatment of cervical dystonia","volume":"94","author":"Lu CS","year":"1995","journal-title":"J Formos Med Assoc"},{"key":"e_1_2_11_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8619(08)80004-7"},{"key":"e_1_2_11_42_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.3.815"},{"key":"e_1_2_11_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-5597(94)90150-3"},{"key":"e_1_2_11_44_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.4.878"},{"key":"e_1_2_11_45_2","unstructured":"We Move. Management of Dystonia with Botulinum Toxin Type A (BOTOX\u00ae) (Edition 2.0). We Move 2005."},{"key":"e_1_2_11_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01440.x"},{"key":"e_1_2_11_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)83049-0"},{"key":"e_1_2_11_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21145"},{"key":"e_1_2_11_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/pri.326"},{"key":"e_1_2_11_50_2","volume-title":"Spasmodic Torticollis. Handbook of Rehabilitative Physiotherapy","author":"Bleton J\u2010P","year":"1994"},{"key":"e_1_2_11_51_2","first-page":"219","article-title":"The effect of two different rehabilitation treatments in cervical dystonia: preliminary results in four patients","volume":"18","author":"Smania N","year":"2003","journal-title":"Funct Neurol"},{"key":"e_1_2_11_52_2","unstructured":"Food and Drug Administration. Early Communication about an Ongoing Safety Review of Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B). Available online:http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/ucm070366.htmLast updated 21\/05\/2009; accessed 17\/12\/09."},{"key":"e_1_2_11_53_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.53.8.640"},{"key":"e_1_2_11_54_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.4.1066"},{"key":"e_1_2_11_55_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.8.1213"},{"key":"e_1_2_11_56_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199008000-00011"},{"key":"e_1_2_11_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870060210"},{"key":"e_1_2_11_58_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.54.9.813"},{"key":"e_1_2_11_59_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20403"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1331.2010.03130.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1331.2010.03130.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T12:48:24Z","timestamp":1694609304000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1331.2010.03130.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,15]]},"references-count":58,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1111\/j.1468-1331.2010.03130.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03130.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,15]]},"assertion":[{"value":"2010-07-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}